Parkway Accelerates Go-To-Market Strategy with New Centre for Brine Technologies
Rundes Icon von GOLDINVEST - Das Investor-Magazin für Rohstoff-News und Rohstoff-Aktien
Editorial Team
Rundes Icon von GOLDINVEST - Das Investor-Magazin für Rohstoff-News und Rohstoff-Aktien
Editorial Team

Comprehensive Update Including ‘Strategic Developments’ Announced

The Australian wastewater cleantech Parkway Corporate (ASX: PWN; FRA: 4IP) has systematically expanded its technical and practical capabilities over the past quarter. According to the recently published quarterly report for December 2023, Parkway has leased a warehouse where a new ‘Centre for Brine Technologies’ is currently being established. The warehouse is adjacent to the existing PPS facility in Melbourne, which also serves as the headquarters of the Parkway Group. The new center aims to improve in-house analytical capabilities and test customer-specific brine treatment on a large pilot scale. In particular, the new center will be used to advance the construction of modular containerized systems with Parkway’s PPT technologies. Existing strategic partners as well as potential customers and cooperation partners support the Center for Brine Technologies and want to use the new possibilities for their purposes.

Go-To-Market Strategy – Work on Standard Design

Parkway Corporate has set out to achieve the transition to commercialization of its PPT technologies (see Figure 1) in 2024. The Parkway management believes that a standardized modular plant design for upstream brine concentration best meets customer requirements. Such standard containers with PPT technologies would, according to Parkway’s assessment, also be attractive for applications outside the CSG industry in Queensland. With regard to CSG companies in Queensland, Parkway believes it can offer an extremely attractive brine concentration service (lower costs, better results) based on toll treatment.

Parkway has already ordered parts for a large-scale pilot plant to be tested in the coming months at the Centre for Brine Technologies. The company expects to be able to reduce the costs of building and maintaining brine tanks by introducing certain upstream technologies. Thanks to this optimization, the company aims to offer the industry a permanently cost-effective solution for dewatering residual brines. Through targeted investment in new capabilities, Parkway aims to build, own and operate (BOO) projects of different sizes in the future, possibly together with one or more partners, depending on the project-specific parameters.

As of December 31, 2023, the company had cash reserves of AUD 3.90 million. The reported cash balance does not take into account existing grant entitlements, the expected R rebate for FY23 ($0.53 million), or other receivables. Parkway attributes the net cash outflow in the past quarter to ongoing investments in the technology portfolio, including the Center for Brine Technologies, as well as the expansion of PPS activities, including funding ongoing work.

Parkway has announced a comprehensive update including ‘strategic developments’ for February 2024.

Newsletter

Don't miss any news and stay informed about the commodity market at all times!

Risk Notice Disclaimer

I. Information Function and Disclaimer
GOLDINVEST Consulting GmbH offers editors, agencies, and companies the opportunity to publish comments, analyses, and news on www.goldinvest.de. The content is solely for general information and does not replace individual, professional investment advice. This does not constitute financial analysis or sales offers, nor is there a call to action to buy or sell securities. Decisions made based on the published information are made entirely at your own risk. No contractual relationship is established between GOLDINVEST Consulting GmbH and the readers or users, as our information relates exclusively to the company and not to personal investment decisions.

II. Risk Disclosure
The acquisition of securities involves high risks that can lead to the total loss of invested capital. Despite careful research, GOLDINVEST Consulting GmbH and its authors assume no liability for financial losses or the content guarantee regarding timeliness, accuracy, adequacy, and completeness of the published information. Please also note our further terms of use.

III. Conflicts of Interest
In accordance with §34b WpHG and §48f Para. 5 BörseG (Austria), we point out that GOLDINVEST Consulting GmbH and its partners, clients, or employees hold shares in the above-mentioned companies. Furthermore, there is a consulting or other service contract between these companies and GOLDINVEST Consulting GmbH, and it is possible that GOLDINVEST Consulting GmbH may buy or sell shares of these companies at any time. These circumstances may lead to conflicts of interest, as the above-mentioned companies compensate GOLDINVEST Consulting GmbH for reporting.